Getting a health-benefit denial can feel personal, confusing, and urgent all at once. A plan says a treatment is “not medically necessary,” “experimental,” or outside the approved level of care, and suddenly the conversation shifts from health to paperwork. If you are new to the process, external review is often the part that sounds the most intimidating — but it is also one of the most important patient protections available.
In simple terms, external review is a second look at certain health-plan denials by an independent third party that is not connected to the plan. Under federal law, many consumers have a right to this kind of review after an internal appeal, and in urgent cases the process can move faster. HealthCare.gov explains that standard external reviews are generally decided within 45 days, while expedited reviews are generally decided within 72 hours or less, depending on medical urgency. CMS and the U.S. Department of Labor describe external review as an independent process available for many denials after internal appeals are exhausted, with some exceptions and plan-specific rules.
In this post you’ll learn what external review is, when it may apply, how it works, where people get tripped up, and when legal help may be worth exploring. If you want a broader overview of the right itself before diving into the step-by-step details, it may help to start with this plain-language explanation of what independent review rights look like after a plan denial.
<aside> 💡 Scroll to the bottom for every post in this series.
</aside>
External review is not the same as calling customer service again, and it is not just another internal complaint. It is a formal review by an independent review organization or a state or federal external review system.
According to HealthCare.gov’s glossary, external review is available after certain denials involving medical necessity, appropriateness, health care setting, level of care, effectiveness of a covered benefit, experimental or investigational treatment, and rescissions of coverage. If the independent reviewer overturns the denial, the plan is generally required to accept that decision.
That last point matters. A lot of denials turn on technical medical-judgment questions rather than simple billing errors. A plan may say inpatient care was unnecessary, a drug was not appropriate for the diagnosis, or a therapy remains investigational. External review exists in part because these are the kinds of calls where independent clinical judgment may matter.
Before the Affordable Care Act, appeal rights varied widely by state, plan type, and policy language. Federal reforms standardized many parts of the process. CMS explains that ACA-era rules created more uniform internal and external appeals protections for many health plans, giving consumers access to outside review when a plan upholds a denial.
State law still matters, and plan type still matters. Some reviews go through a state external review process. Others go through a federal external review process or a process handled by an independent review organization under federal requirements. CMS notes that plans generally comply with either the applicable state external review system or the federal one.
For beginners, the main takeaway is this: the path may differ, but the idea is the same. Someone independent from the plan reviews the denial.
Not every dispute is a fit for external review, but many important denials are. Authoritative federal guidance commonly points to denials involving: